PDT Study for Exudative AMD With PCV

PHASE4CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2010

Conditions
Age Related Macular Degeneration
Interventions
PROCEDURE

Ocular photodynamic therapy with verteporfin

Ocular photodynamic therapy with 6 mg per meter squar of body sarface of verteporfin with PDT lazer application for 83 seconds

Trial Locations (17)

Unknown

Nagoya City University Hospital, Aichi

Nagoya University, Aichi

Gunma University, Gunma

Shiga University of Medical Science, Shiga

Toho University, Tokyo

Tokyo University Ohashi Medical Center, Tokyo

Yamanashi University, Yamanashi

812-0054

Kyushu University, Fukuoka

960-1295

Fukushima Medical University School of Medicine, Fukushima

761-0793

Kagawa University, Kagawa

606-8507

Kyoto University, Kyoto

565-0871

Osaka University, Osaka

570-8507

Kansai Medical University Takii Hospital, Osaka

573-1191

Kansai Medical University Hirakata Hospital, Osaka

060-8604

Sapporo City general hospital, Sapporo

101-8309

Surugadai Nihon University Hospital, Tokyo

181-8611

Kyorin University, Tokyo

All Listed Sponsors
lead

Ophthalmic PDT Study Group

OTHER

NCT00331435 - PDT Study for Exudative AMD With PCV | Biotech Hunter | Biotech Hunter